Stock 300434 SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sichuan Goldstone Asia Pharmaceutical Inc.

Equities

300434

CNE100001YX5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
8.55 CNY -1.61% Intraday chart for Sichuan Goldstone Asia Pharmaceutical Inc. -5.94% -22.69%
Apr. 25 Sichuan Goldstone Asia Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Hangzhou Solipharma Technology Development Co., Ltd. announced that it expects to receive CNY 69.4857 million in funding from Sichuan Goldstone Asia Pharmaceutical Inc., Hangzhou Huolongguo Investment Management Co., Ltd. and another investor CI

Business Summary

Sichuan Goldstone Asia Pharmaceutical Inc., formerly Sichuan Goldstone Orient New Material Equipment Inc, is a China-based company principally engaged in the production and sales of pharmaceutical products, as well as drug agency business. Its main products include health products, cracks and small cracks. The Company is also engaged in the machinery manufacturing business, as well as property leasing and management business. Its machinery products mainly include steel reinforced plastic pipe production line, bead winding steel reinforced pipe production line, production line equipment parts and other equipment. The Company mainly operates its businesses in domestic market.

Number of employees: 1,962

Sales per Business

CNY in Million2022Weight2023Weight Delta
Crack, Small Crack
61.1 %
728 58.6 % 738 61.1 % +1.38%
Other Pharmaceutical Products
16.6 %
180 14.5 % 201 16.6 % +11.83%
OEM and Wholesale and Retail Pharmaceuticals
8.6 %
152 12.3 % 104 8.6 % -31.50%
Complete Production Line
6.4 %
98 7.9 % 78 6.4 % -20.60%
Health Product
3.5 %
27 2.1 % 42 3.5 % +60.27%
Real Estate Leasing and Management
3.2 %
42 3.4 % 38 3.2 % -9.05%
Mechanical Parts and Others
0.6 %
11 0.9 % 7 0.6 % -34.27%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.6 %
1,231 99.1 % 1,205 99.6 % -2.12%
Overseas
0.4 %
12 0.9 % 4 0.4 % -62.02%

Managers

Managers TitleAgeSince
Bao Kang Wei CEO
 Chief Executive Officer 56 19-12-08
Qing Guo Wang DFI
 Director of Finance/CFO 49 22-08-24
Zhi Yong Zheng BRD
 Director/Board Member 56 17-10-12
Qiang Lin BRD
 Director/Board Member 60 04-06-30
Yi Xi Kuai BRD
 Director/Board Member 66 04-06-30
Xin He IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Jin Lou BRD
 Director/Board Member 94 17-10-12
Bao Kang Wei CEO
 Chief Executive Officer 56 19-12-08
Yi Xi Kuai BRD
 Director/Board Member 66 04-06-30
Qiang Lin BRD
 Director/Board Member 60 04-06-30
Run Xiu Li BRD
 Director/Board Member 55 04-06-30
Zhi Yong Zheng BRD
 Director/Board Member 56 17-10-12
Wen Jie Ma BRD
 Director/Board Member 42 17-10-12
Xiao Xia Sheng BRD
 Director/Board Member 47 20-11-17
Jian Quan Miao BRD
 Director/Board Member 64 20-11-17
Jin Wang CHM
 Chairman 61 20-11-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 401,743,872 156,631,424 ( 38.99 %) 0 38.99 %

Shareholders

NameEquities%Valuation
Zhi Yong Zheng
0.4517 %
906,726 0.4517 % 1 M ¥
Bosera Asset Management Co., Ltd.
0.2280 %
457,600 0.2280 % 570 618 ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.0533 %
106,900 0.0533 % 133 302 ¥
Jyah Asset Management Co. Ltd.
0.0156 %
31,300 0.0156 % 39 030 ¥
Guotai Asset Management Co., Ltd.
0.000498 %
1,000 0.000498 % 1 247 ¥
Gfund Management Co., Ltd.
0.000199 %
400 0.000199 % 499 ¥

Company contact information

Sichuan Goldstone Asia Pharmaceutical, Inc.

8/F, Area A1 Dadi New Guanghua Plaza

610072, Chengdu

+

http://www.goldstone-group.com
address Sichuan Goldstone Asia Pharmaceutical Inc.(300434)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC. Stock Sichuan Goldstone Asia Pharmaceutical Inc.
-22.69% 474M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+18.04% 42.95B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+16.92% 21.38B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.33% 15.05B
CIPLA LIMITED Stock Cipla Limited
+19.27% 14.45B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+56.12% 13.04B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.73% 6.72B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.21% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300434 Stock
  4. Company Sichuan Goldstone Asia Pharmaceutical Inc.